UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

                  For the quarterly period ended March 31, 2005

                                       OR

[ ] TRANSITION REPORT PURSAUNT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

For the transition period from                             to
                              --------------------------------------------------

Commission File Number:                           333-118568
                       ---------------------------------------------------------


                     NATIONAL PATENT DEVELOPMENT CORPORATION
             (Exact Name of Registrant as Specified in its Charter)

         Delaware                                         13-4005439
------------------------------------                   -------------------------
(State or other jurisdiction of                        (I.R.S. Employer
incorporation or organization                           Identification No.)

777 Westchester Avenue, White Plains, NY                       10604
--------------------------------------------------------------------------------
(Address of principal executive offices)                    (Zip code)

                                 (914) 249-9700
--------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange act of 1934 during
the preceding 12 months (or for such shorter period) that the registrant was
required to file such reports and (2) has been subject to such filing
requirements for the past 90 days. Yes X   No

Indicate by check mark whether the registrant is an accelerated filer (as
defined in Rule 12(b)-2 of the Exchange Act). Yes             No      X


Indicate the number of shares outstanding of each of issuer's classes of common
stock as of May 5, 2005:

            Common Stock                                17,801,043 shares


<PAGE>




            NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

                                TABLE OF CONTENTS


                                                                    Page No.

                          Part I. Financial Information

Item 1. Financial Statements

        Condensed Consolidated Statements of Operations-
           Three Months Ended March 31, 2005 and 2004 (Unaudited)     1

        Condensed Consolidated Statements of Comprehensive Loss-
           Three Months Ended March 31, 2005 and 2004 (Unaudited)     2

        Condensed Consolidated Balance Sheets -
           March 31, 2005 (Unaudited) and December 31, 2004           3

        Condensed Consolidated Statements of Cash Flows -
           Three Months Ended March 31, 2005 and 2004 (Unaudited)     4

        Notes to Condensed Consolidated Financial Statements          5

Item 2. Management's Discussion and Analysis of Financial
           Condition and Results of Operations                       13

Item 3. Quantitative and Qualitative Disclosure about Market Risk    20

Item 4. Controls and Procedures                                      20

                      Part II. Other Information

Item 6. Exhibits                                                     21

Signatures                                                           22




<PAGE>



4
                          PART I. FINANCIAL INFORMATION

            NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)
                      (in thousands, except per share data)

<TABLE>
<CAPTION>
                                                                          Three Months Ended
                                                                              March 31,
                                                                           2005            2004
                                                                           ----            ----
<S>                                                                     <C>              <C>
  Sales                                                                 $30,077          $29,121
  Cost of sales                                                          25,528           24,356
                                                                        -------          -------
  Gross margin                                                            4,549            4,765

  Selling, general and administrative expenses                           (5,110)          (4,669)
                                                                       ---------         --------

        Operating  profit (loss)                                           (561)              96

  Interest expense                                                         (372)            (205)
  Investment and other income (loss)                                        163               (95)
                                                                       --------      -------------

       Loss before income taxes and  minority interest                     (770)            (204)

  Income tax (expense) benefit                                              (43)              26
                                                                       ---------          ------

       Loss before minority interest                                       (813)            (178)

  Minority interest                                                          (7)            (119)
                                                                       ---------        ---------

       Net loss                                                        $   (820)        $   (297)
                                                                       =========        =========

  Net loss per share
       Basic and diluted                                               $  (0.05)         $  (0.02)
                                                                       =========         =========


</TABLE>






          See accompanying notes to consolidated financial statements.


<PAGE>



            NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES
             CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
                                   (Unaudited)
                                 (in thousands)
<TABLE>

<CAPTION>
                                                                                 Three Months Ended
                                                                                     March 31,
                                                                                  2005             2004
                                                                                  ----             ----
<S>                                                                             <C>           <C>
  Net loss                                                                      $ (820)       $   (297)

  Other comprehensive income (loss), before tax:
  Net unrealized gain (loss) on available-for-sale-securities                      769            (486)
  Reclassification adjustment for (gain) loss on securities sold
  included in net loss                                                            (152)            140
  Net unrealized gain (loss) on interest rate swap, net of minority
  interest                                                                         151              (162)
                                                                              --------      -------------

  Comprehensive loss before tax                                                    (52)           (805)

  Income tax (expense) benefit related to items of other comprehensive
  loss                                                                             (63)             63
                                                                                -------          -----

  Comprehensive loss                                                            $ (115)        $  (742)
                                                                                =======        ========


</TABLE>









          See accompanying notes to consolidated financial statements.


                                        2

<PAGE>


                     NATIONAL PATENT DEVELOPMENT CORPORATION
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                 (in thousands)

<TABLE>
<CAPTION>
                                                                              March 31,         December 31,
                                                                               2005                     2004
                                                                               ----                     ----
                                                                           (unaudited)
Assets
Current assets
<S>                                                                           <C>                <C>
Cash and cash equivalents                                                     $   6,278          $     2,087
Accounts receivable, less allowance
  for doubtful accounts of $356 and $306                                         19,545               11,410
Receivable from GP Strategies Corporation                                             -                5,000
Inventories                                                                      30,666               30,698
Prepaid expenses and other current assets                                           721                  530
Property held for sale                                                            1,595                1,595
                                                                               --------             --------
Total current assets                                                             58,805               51,320
Marketable securities available for sale                                          1,183                1,416
Property, plant and equipment, net                                                3,137                2,876
Investment in Valera                                                              1,590                1,590
Other assets                                                                      3,508                3,272
                                                                              ---------            ---------
Total assets                                                                    $68,223              $60,474
                                                                                =======              =======

Liabilities and stockholder's equity
Current liabilities
Current maturities of long-term debt                                           $    372           $    1,967
Short term borrowings                                                            29,005               18,784
Accounts payable and accrued expenses, including due    to
affiliates of $210 and $0, respectively                                          14,638               15,386
Mortgage collateralized by property held for sale                                 1,147                1,155
                                                                               --------             --------
Total current liabilities                                                        45,162               37,292
Long-term debt less current maturities                                            1,308                1,395
Other liabilities                                                                   283                  258
                                                                              ---------             --------
Total liabilities                                                                46,753               38,945

Minority interest                                                                 1,825                1,769

Stockholder's equity
Common Stock                                                                        178                  178
Additional paid-in capital                                                       24,761               24,761
Accumulated deficit                                                              (5,663)              (4,843)
Accumulated other comprehensive income (loss)                                       369                 (336)
                                                                            -----------           -----------
Total stockholder's equity                                                       19,645               19,760
                                                                             ----------             --------
Total liabilities and stockholder's equity                                      $68,223              $60,474
                                                                                =======              =======
</TABLE>

          See accompanying notes to consolidated financial statements.


                                       3
<PAGE>

            NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)
                                 (in thousands)

<TABLE>
<CAPTION>
                                                                                      Three Months Ended
                                                                                          March 31,
                                                                                      2005           2004
                                                                                      ----           ----
   Cash flows from operations:
<S>                                                                                 <C>               <C>
   Net loss                                                                         $ (820)           $ (297)
   Adjustments to reconcile net loss to
    net cash provided by (used in) operating activities:
   Depreciation and amortization                                                       177               174
   Minority interest                                                                     7               119
   Net (gain) loss on marketable securities                                           (152)               97
   Allocation of expenses and taxes from GP Strategies                                   -               463
   Loss on sale of fixed assets                                                         79                 -
   Changes in other operating items                                                 (9,116)           (6,373)
                                                                                   --------       -----------
   Net cash used in operations                                                      (9,825)           (5,817)

   Cash flows from investing activities:
   Additions to property, plant and equipment, net                                    (550)             (124)
   Proceeds from sale of investments                                                 1,002               872
   Proceeds from sale of fixed assets                                                   33                 -
   Advances to GP Strategies                                                            -             (1,138)
                                                                                 ---------          ---------
   Net cash provided by (used in) investing activities                                 485              (390)

   Cash flows from financing activities:
   Distribution to GP Strategies                                                         -               (57)
   Repayment of receivable from GP Strategies                                        5,000                 -
   Proceeds from short-term borrowings                                              10,221             5,959
   Repayment of long-term debt                                                      (1,690)              (95)
                                                                                -----------            ------
   Net cash provided by financing activities                                        13,531             5,807
                                                                                  --------           -------

   Net increase (decrease) in cash and cash equivalents                              4,191              (400)
   Cash and cash equivalents at beginning of period                                  2,087               602
                                                                                ----------            ------
   Cash and cash equivalents at end of period                                       $6,278             $ 202
                                                                                  ========             =====

</TABLE>



   See accompanying notes to the condensed consolidated financial statements.




                                       4
<PAGE>



            NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES

              Notes to Condensed Consolidated Financial Statements

                   Three months ended March 31, 2005 and 2004
                                   (Unaudited)


1.       Basis of presentation and summary of significant accounting policies

Basis of presentation

The accompanying Condensed Consolidated Balance Sheet as of March 31, 2005 and
the Condensed Consolidated Statements of Operations and Cash Flows for the three
months ended March 31, 2005 and 2004 have not been audited, but have been
prepared in conformity with accounting principles generally accepted in the
United States for interim financial information and with the instructions to
Form 10-Q and Article 10 of Regulation S-X. These financial statements should be
read in conjunction with the audited consolidated financial statements and notes
thereto for the year ended December 31, 2004 as presented in our Annual Report
on Form 10-K. In the opinion of management, this interim information includes
all material adjustments, which are of a normal and recurring nature, necessary
for a fair presentation. The results for the 2005 interim periods are not
necessarily indicative of results to be expected for the entire year.

Description of business. National Patent Development Corporation (the "Company"
or "National Patent Development "), through its wholly owned subsidiary, MXL
Industries, Inc. ("MXL"), manufactures polycarbonate parts requiring strict
adherence to optical quality specifications, and in the application of abrasion
and fog resistant coating to these parts. Products include shields and face
masks and non-optical plastic products. The Company's 64% owned subsidiary, Five
Star Products, Inc. ("Five Star"), is engaged in the wholesale distribution of
home decorating, hardware and finishing products. It serves over 3,500
independent retail dealers in twelve states in the Northeast. Products
distributed include paint sundry items, interior and exterior stains, brushes,
rollers, caulking compounds and hardware products

Revenue recognition. Revenue on product sales is recognized at the point in time
when the product has been shipped, title and risk of loss has been transferred
to the customer, and the following conditions are met: persuasive evidence of an
arrangement exists, the price is fixed and determinable, and collectibility of
the resulting receivable is reasonably assured. Allowances for estimated returns
and allowances are recognized when sales are recorded.

Shipping and handling costs. Shipping and handling costs are included as a part
of selling, general and administrative expense. These cost amounted to
$1,228,000 and $1,124,000, for the three months ended March 31, 2005 and 2004,
respectively.

Inventories. Inventories are valued at the lower of cost or market, using the
first-in, first-out method.

Derivatives and hedging activities. The interest rate swap and interest rate
collar entered into by the Five Star in connection with its Loan and Security
Agreement (see Note 5) is being accounted for under SFAS No. 133, as amended,
"Accounting for Derivative Instruments and Hedging Activities." SFAS No. 133
requires all derivatives to be recognized in the balance sheet at fair value.
Derivatives that are not hedges must be adjusted to fair value through earnings.
If the derivative is a cash flow hedge, changes in the fair value of the

                                                                (Continued)
                                       5
<PAGE>

derivative are recognized in other comprehensive income until the hedged item is
recognized in earnings. The ineffective portion of a derivative's change in fair
value is immediately recognized in earnings. Changes in the fair value of the
interest rate swap, which has been designated as a cash flow hedge, were
recognized in other comprehensive income. Changes in the fair value of the
interest rate collar are recognized in earnings. For the three months ended
March 31, 2005 the Company recognized a loss of $25,000 as part of other income
for the changes in the fair value of the interest rate collar.

Recent accounting pronouncements. During December 2004, the Financial Accounting
Standards Board ("FASB") issued a new standard entitled Statement of Financial
Accounting Standards ("SFAS") 123R, Share-Based Payment, which would revise SFAS
No. 123, Accounting for Stock Based Compensation, and amend SFAS No. 95,
Statement of Cash Flows. Among other items, the new standard would require the
expensing, in the financial statements, of stock options issued by the Company.
The new standard will be effective July 1, 2005, for calendar year companies.
The Company is currently evaluating the method of adoption of SFAS No. 123R,
including the valuation methods and assumptions that underlie the valuation of
the awards. As permitted under SFAS No. 123 the Company currently accounts for
share-based payments to employees using Accounting Principles Board ("APB")
Opinion No. 25 intrinsic value method, and as such, recognizes no compensation
cost for employee stock options. Accordingly the adoption of SFAS No. 123R fair
value method could have a significant impact on the Company's results of
operations, although it will have no impact on the Company's overall financial
position. The impact of adoption of SFAS No. 123R cannot be predicted at this
time, because it will depend on levels of share-based payments in the future.
However had the Company adopted SFAS No. 123R in prior periods, the impact of
that statement would have approximated the impact of SFAS No. 123 as described
in the disclosure of pro forma net income and earnings per share shown in Note 2
under "Stock based compensation"

In November 2004, the FASB issued SFAS No. 151, Inventory Costs, an amendment to
ARB No. 43, Chapter 4 (FAS 151). FAS 151 amends Accounting Research Bulleting
No. 43, to clarify that abnormal amounts of idle facility expense, freight,
handling costs and wasted material (spoilage) should be recognized as current
period charges. In addition, FAS 151 requires that allocation of fixed
production overhead to inventory be based on the normal capacity of the
production facilities. The Company is required to adopt FAS 151 beginning
January 1, 2006. The Company is currently assessing the impact that FAS 151 will
have on its results of operations, financial position or cash flows.


                                                                (Continued)

                                       6
<PAGE>



2.       Stock based compensation.

The Company applies the intrinsic value-based method of accounting prescribed by
Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued
to Employees," and related interpretations, in accounting for options to acquire
GP Strategies Corporation ("GP Strategies") common stock granted to MXL
employees under the GP Strategies stock option plan. As such, compensation
expense would be recorded on the date of grant only if the current market price
of the underlying stock exceeded the exercise price. The difference between the
quoted market price as of the date of the grant and the contractual purchase
price of shares is charged to operations over the vesting period. SFAS No. 123,
"Accounting for Stock-Based Compensation," established accounting and disclosure
requirements using a fair value-based method of accounting for stock-based
employee compensation plans. As allowed by SFAS No. 123, the Company has elected
to continue to apply the intrinsic value-based method of accounting described
above, and has adopted the disclosure requirements of SFAS No. 123.

Pro forma net loss and loss per share disclosures as if compensation expense was
recorded based on the fair value of options granted under the Five Star
Products, Inc. 1994 Five Star Plan have been presented in accordance with the
provisions of SFAS No. 123, is as follows for the three months ended March 31,
2005 and 2004 (in thousands, except per share amounts):

<TABLE>
<CAPTION>

                                                                 Three months ended
                                                                      March 31,
                                                               2005               2004
                                                               ----               ----
<S>                                                            <C>                 <C>
   Net loss - As reported                                      $(820)              $(297)
   Compensation expense, net of tax
               Five Star stock options (1)                        (2)                 (2)
                                                             --------              ------
               Pro forma net loss                              $(822)              $(299)
   Basic and diluted loss per share
               As reported                                     $(.05)             $(.02)
               Pro forma net loss per share                    $(.05)             $(.02)
</TABLE>

(1) Expense relates to option grants made by Five Star prior to the acquisition
of a controlling interest in Five Star by the Company.

3.       Per share data

Basic and diluted loss per share for the three months ended March 31, 2004 is
based upon the 17,798,585 common shares of National Patent Development issued in
2004 and distributed in the spin-off, which are treated as outstanding for the
period. Basic and diluted loss per share for the three months ended March 31,
2005 is based upon the actual number of National Patent Development shares
outstanding for the period. Outstanding warrants to acquire 1,423,887 common
shares issued in December 2004 were not included in the 2005 diluted
computation, as their effect would be anti-dilutive.

                                                                (Continued)

                                       7
<PAGE>


Loss per share for the three months ended March 31, 2005 and 2004 are as follows
(in thousands, except per share amounts):



                                                        Three months ended
                                                           March 31,
                                                     2005             2004
                                                     ----             ----
       Basic and Diluted EPS
       Net loss                                       $(820)           $(297)
       Weighted average shares
         outstanding, basic and diluted              17,799           17,799
       Basic and diluted loss per share              $(.05)            $(.02)

4.       Long-term debt

Long-term debt

Long-term debt is comprised of the following (in thousands):

                                                   March 31,        December 31,
                                                      2005              2004
                                                   -------           -------
  MXL Pennsylvania Mortgage (a)                      $1,280           $1,305
  AOtec Debt and Notes (b)                              364              421
  Valera stock acquisition debt (see Note 9(a))           -            1,590
  Capital lease obligations                              36               46
                                                   --------               --
                                                      1,680            3,362
                                                    -------          -------
  Less current maturities                              (372)          (1,967)
                                                   ---------         --------
                                                     $1,308           $1,395

(a) On March 8, 2001, MXL mortgaged its real estate and fixtures on its property
in Pennsylvania for $1,680,000. The loan requires monthly repayments of $8,333
plus interest at 2.5% above the one month LIBOR rate and matures on March 8,
2011, when the remaining amount outstanding of approximately $680,000 is due in
full. The loan is guaranteed by GP Strategies.

(b) In September 2003, MXL purchased machinery, equipment and inventory from
AOtec LLC ("AOtec"), located in the Massachusetts area, for $1,100,000, subject
to adjustment. In connection with this purchase, the Company valued the
machinery and equipment at approximately $900,000, the inventory at
approximately $350,000 and recorded an accrued expense of $150,000. MXL paid
$100,000 of the purchase price in cash and issued three notes, in the amount of
$450,000, $275,000 and $275,000 each, due October 1, 2003, August 5, 2004 and
August 5, 2005, respectively (collectively, the "AOtec Notes"). The AOtec Notes
bear interest on the unpaid principal amount at the rate of 4% per annum. On

                                                                (Continued)
                                       8
<PAGE>

October 1, 2003, MXL borrowed $700,000 from a bank under an agreement to finance
the purchase price (the "AOtec Debt") and used a portion of the proceeds to pay
the $450,000 note. The AOtec Debt bears interest at the rate of 5.89 % per
annum, is payable monthly for three-years and is secured by the machinery and
equipment purchased from AOtec. GP Strategies guaranteed the AOtec Debt. The
AOtec Notes amounting to $550,000 as of March 31, 2005 and December 31, 2004 are
classified as short term borrowings on the Company's Consolidated Balance Sheets
and are not included in the table above. MXL is currently negotiating a
reduction in the amounts due under the AOtec Notes with maturity dates of August
5, 2004 and 2005, resulting from a dispute over the purchase price. According to
the contract of sale, the payments due pursuant to the AOtec Notes were subject
to an offset and withholding by MXL. The parties are attempting to resolve this
matter; however there is no guarantee that MXL will successfully negotiate the
reduction of the AOtec Notes.

5. Short term borrowings

Five Star short-term borrowings

In 2003, Five Star obtained a Loan and Security Agreement (the "Loan Agreement")
with Bank of America Business Capital (formerly Fleet Capital Corporation) (the
"Lender"). The Loan Agreement has a five-year term, with a maturity date of June
30, 2008. The Loan Agreement, as amended in March 2005, provides for a
$30,000,000 revolving credit facility, which allows Five Star to borrow based
upon a formula of up to 55% of eligible inventory and 80% of eligible accounts
receivable, as defined therein. The interest rates under the Loan Agreement
consist of LIBOR plus a credit spread of 2% (4.69% at March 31, 2005) for
borrowings not to exceed $15,000,000 and the prime rate (5.75% at March 31,
2005) for borrowings in excess of the above-mentioned LIBOR-based borrowings.
The credit spreads can be reduced in the event that Five Star achieves and
maintains certain performance benchmarks. At March 31, 2005 and December 31,
2004, approximately $27,955,000 and $18,234,000 was outstanding under the Loan
Agreement and approximately $521,000 and $434,000 was available to be borrowed,
respectively. Substantially all of Five Star's assets are pledged as collateral
for these borrowings. Under the Loan Agreement Five Star is subject to covenants
requiring minimum net worth, limitations on losses, if any, and minimum or
maximum values for certain financial ratios. As of March 31, 2005 Five Star was
in compliance with all required covenants.

In April 2005, Five Star amended the Loan Agreement to allow it to increase the
maximum amount that can be borrowed under the revolving credit facility to
$30,800,000 through June 30, 2005; reverting back to a maximum of $28,000,000 on
July 1, 2005.

In connection with the Loan Agreement, Five Star also entered into a derivative
transaction with the Lender. The derivative transaction is an interest rate swap
and has been designated as a cash flow hedge. Effective July 1, 2004 through
June 30, 2008, Five Star will pay a fixed interest rate of 3.38% to the Lender
on notional principal of $12,000,000. In return, the Lender will pay to Five
Star a floating rate, namely, LIBOR, on the same notional principal amount. The
credit spread under the new Loan Agreement is not included in, and will be paid

                                                                (Continued)
                                       9
<PAGE>

in addition to this fixed interest rate of 3.38%. The fair value of the interest
rate swap amounted to $341,000 and $105,000 at March 31, 2005 and December 31,
2004, respectively, and is included in other assets in the accompanying balance
sheets.

On June 17, 2004, Five Star also entered into a derivative interest rate collar
transaction during the period from July 1, 2004 through June 30, 2008 on
notional principal of $12,000,000. The transaction consists of an interest rate
floor of 2.25%, whereas if LIBOR is below 2.25%, the Lender will pay to Five
Star the difference between LIBOR and 2.25%, on the same notional principal
amount. The transaction also consists of an interest rate cap of 5.75%, whereas
if LIBOR is above 5.75%, Five Star will pay to the Lender the difference between
LIBOR and 5.75%, on the same notional principal amount.

MXL short-term borrowings

On March 1, 2005, MXL obtained a Line of Credit Loan (the "MXL Line") from M&T
Bank with a one year term, maturing on March 1, 2006. The MXL Line provides for
a $1,000,000 revolving credit facility, which is secured by MXL's eligible
accounts receivable, inventory and a secondary claim on the Lancaster, PA
property. The interest rates under the MXL Line consist of LIBOR plus a credit
spread of 3% or the prime rate plus a credit spread of 0.25%. The MXL Line is
subject to an unused commitment fee of 0.25% of the average daily unused balance
of the line payable quarterly. National Patent Development has guaranteed the
MXL Line. At March 31, 2005, $500,000 was outstanding under the MXL Line and $0
was available to be borrowed.

6.       Inventories

Inventories are comprised of the following (in thousands):

                                  March 31, 2005             December 31, 2004
                                  --------------             -----------------
   Raw materials                   $      780                 $      753
   Work in process                        331                        277
   Finished goods                      29,555                     29,668
                                      -------                   --------
                                      $30,666                    $30,698
                                      =======                    =======

7.       Business segments

The operations of the Company currently consist of the following two business
segments, by which the Company is managed.

The MXL Segment, formerly called the Optical Plastics Segment, manufactures
precision coated and molded optical plastic products. MXL is a specialist in the
manufacture of polycarbonate parts requiring adherence to strict optical quality
specifications, and in the application of abrasion and fog resistant coatings to
those parts.

                                                                (Continued)
                                       10
<PAGE>

The Five Star Segment, formerly called the Home Improvement Distribution
Segment, distributes paint sundry items, interior and exterior stains, brushes,
rollers, caulking compounds and hardware products on a regional basis.

The following tables set forth the sales and operating income (loss) of each of
the Company's operating segments (in thousands):

                                        Three months
                                        ended March 31,
                                      2005           2004
                                      ----           ----
      Sales
      Five Star                     $28,239         $26,991
      MXL                             1,838           2,130
                                   ---------      ----------
                                    $30,077         $29,121

                                                       Three months
                                                       ended March 31,
                                                  2005            2004
                                                  ----            ----
      Segment operating income (loss)
      Five Star                                 $  478            $700
      MXL                                         (504)           (304)
                                               --------      ----------
                                                  $(26)           $396

A reconciliation of the segment operating income (loss) to loss before income
tax (expense) benefit and minority interests in the condensed consolidated
statements of operations is shown below (in thousands):

                                                     Three months
                                                    ended March 31,
                                                   ------------------------
                                                   ---------- -------------
                                                    2005             2004
                                                    ----             ----
       Segment operating income (loss)              $(26)            $396
       Corporate and other general and
            administrative expenses                 (535)            (300)
       Interest expense                             (372)            (205)
       Investment and other income                   163              (95)
                                                   -----       -----------
       Loss before income tax
             expense and minority interests        $(770)           $(204)

8.       Capital contribution

On July 30, 2004, GP Strategies agreed to make an additional capital
contribution to National Patent Development, in an amount equal to the first $5
million of any proceeds (net of litigation expenses and taxes incurred, if any),

                                                                (Continued)

                                       11
<PAGE>

            NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES
              Notes to Condensed consolidated Financial Statements
                      Three months March 31, 2005 and 2004
                                   (Unaudited)

and 50% of any proceeds (net of litigation expenses and taxes incurred, if any)
in excess of $15 million, received with respect to its claims in connection with
the Learning Technologies acquisition. GP Strategies has received $13.7 million
of net proceeds from such claims and, pursuant to such agreement, in January
2005 GP Strategies made a $5 million additional capital contribution to National
Patent Development.

9. Related party transactions

a) On November 12, 2004, the Company entered into an agreement to borrow
approximately $1,022,000 from Bedford Oak Partners, which is controlled by
Harvey P. Eisen, a director of the Company, and approximately $568,000 from
Jerome I. Feldman, who is Chairman and Chief Executive Officer of the Company,
to exercise the option to purchase Series B Convertible Preferred shares of
Valera. The loans bore interest at 6% per annum, matured on October 31, 2009,
and were secured by all shares of Valera owned by the Company, including the
purchased shares. The loans were required to be prepaid out of the proceeds
received from the sale of the purchased shares or from any additional capital
contribution received by the Company from GP Strategies out of proceeds received
by GP Strategies from its claims relating to the Learning Technologies
acquisition described in Note 8 above. Bedford Oak Partners and Jerome I.
Feldman are entitled to receive 50% of any profit received by the Company from
the sale of the Valera purchased shares. As described in Note 8 above, GP
Strategies made a $5 million additional capital contribution to the Company. On
January 11, 2005, the Company prepaid the loans, including accrued interest of
approximately $16,000, to Bedford Oak Partners and Jerome I. Feldman out of the
proceeds from the claims relating to the Learning Technologies acquisition.

b) Certain of the Company's executive officers are also executive officers of GP
Strategies and will remain on GP Strategies' payroll. The executive officers
will not receive any salary from the Company; however, they will provide the
Company with management services under a management agreement between GP
Strategies and the Company. GP Strategies charges the Company a management fee
to cover an allocable portion of the compensation of these officers, based on
the time they spend providing services to the Company, in addition to an
allocable portion of certain other corporate expenses. Such fee amounted to
$315,000 for the three months ended March 31, 2005.

The Company has entered into a separate management agreement with GP Strategies
pursuant to which the Company provides certain general corporate services to GP
Strategies. Under this management agreement, the Company charges GP Strategies a
management fee to cover an allocable portion of the compensation of its
employees, based on the time they spend providing services to GP Strategies, in
addition to an allocable portion of corporate overhead related to services
performed for GP Strategies and its subsidiaries. Such fee amounted to $43,000
for the three months ended March 31, 2005.



                                       12
<PAGE>

            NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES
              Notes to Condensed consolidated Financial Statements
                      Three months March 31, 2005 and 2004
                                  (Unaudited)

Item 2. Management's Discussion and Analysis of Financial Condition and
        Results of Operations

General Overview

The Company operates in two segments: MXL, which was formerly called the Optical
Plastics segment, and Five Star, which was formerly called the Home Improvement
Distribution segment. The Company also owns certain other non-core assets,
including an investment in a publicly held company, Millennium Cell; an
approximately 17.7% interest in a private company, Valera Pharmaceuticals; and
certain real estate. National Patent Development monitors Millennium Cell for
progress in the commercialization of Millennium Cell's emerging technology and
monitors Valera Pharmaceuticals for progress in the FDA approval process.

MXL Overview

The primary business of MXL is the manufacture of polycarbonate parts requiring
adherence to strict optical quality specifications, and the application of
abrasion and fog resistant coatings to those parts. MXL also designs and
constructs injection molds for a variety of applications. Some of the products
that MXL produces include:

o   facemasks and shields for recreation purposes and industrial safety
    companies,

o   precision optical systems, including medical optics, military eye wear and
    custom molded and decorated products, and

o   tools, including optical injection mold tools and standard injection mold
    tools.

MXL's manufactures and sells its products to various commercial and government
customers, who utilize MXL's parts to manufacture products that will be
ultimately delivered to the end-user. MXL's government customers include various
offices of the Department of Defense, while MXL's commercial customers are
primarily in the recreation, safety, and security industries. Some of MXL's
consumer based products are considered to be at the high-end of their respective
markets. As a result, sales of MXL's products may decline together with a
decline in discretionary consumer spending; therefore a key performance
indicator that the Company's management uses to manage the business is the level
of discretionary spending in key markets, specifically the United States and
Japan. Other key performance measures used by the Company's management to run
the business include:

o        consumer confidence indices in key markets,
o        sales levels of complementary items in the recreational vehicle market,
         such as motorcycles, RV's and snowmobiles,
o        levels of defense spending, and
o        new OSHA safety standards.


                                       13
<PAGE>

            NATIONAL PATENT DEVELOPMENT CORPORATION AND SUBSIDIARIES


MXL believes that the principal strengths of its business are its
state-of-the-art injection molding equipment, advanced production technology,
high quality standards, and on time deliveries. However, due to the focused
nature of the market, MXL has a limited customer base and tends to be adversely
affected by a loss in business from its significant customers. As a result of
losses of business from certain of its key customers, MXL sales and operating
profits for the past three years have shown a declining trend, reflecting a loss
in market share. To reverse the declining sales trend, a new management team
with significant sales and marketing experience has been established in 2004. To
further grow, MXL not only intends to regain market share in its existing
market, but to leverage its expertise as a molder and coater of optical quality
products by expanding into other markets and products. However, due to the
spin-off, MXL may have less financial resources at its disposal with which to
support and grow the business, as National Patent Development will have a
smaller market capitalization and less access to capital markets than GP
Strategies.

Five Star Overview

Five Star is a publicly held company that is a leading distributor in the United
States of home decorating, hardware, and finishing products. Five Star offers
products from leading manufacturers in the home improvement industry and
distributes those products to retail dealers, which include lumber yards, "do-it
yourself" centers, hardware stores and paint stores. Five Star has grown to be
one of the largest independent distributors in the Northeast United Stated by
providing a complete line of competitively priced products, timely delivery and
attractive pricing and financing terms to its customers.

         The following key factors affect Five Star's financial and operation
performance:

o        its ability to negotiate the lowest prices from its suppliers,
o        its ability to increase revenue by obtaining new customers, while
         maintaining a level fixed cost structure by utilizing its
         existing warehouses,
o        the housing market in general,
o        consumers' confidence in the economy,
o        consumers' willingness to invest in their homes, and
o        weather conditions that are conducive to home improvement projects.

         The following key performance measures are utilized by the Company's
management to run Five Star's business:

o        new U.S. housing starts,
o        sales of existing homes,
o        sales of high margin products to its customers,
o        purchases from each vendor, and
o        performance benchmarks used by Home Depot and Lowe's, such as number of
         stores and square footage, as well as financial benchmarks.



                                       14
<PAGE>

Five Star operates in the Home Improvement market, which has grown in recent
years and for which the Home Improvement Research Institute predicts average
annual industry growth of nearly 5% for the next several years. Nonetheless,
Five Star faces intense competition from large national distributors, smaller
regional distributors, and manufacturers that bypass the distributor and sell
directly to the retail outlet. The principal means of competition for Five Star
are its strategically placed distribution centers and its extensive inventory of
quality, name-brand products. In addition, Five Star's customers face stiff
competition from Home Depot and Lowe's, which purchase directly from
manufacturers. As a result of such competition, while the Home Improvement
market has expanded significantly in recent years, Five Star's revenue has
increased only incrementally, and such revenue would have declined if Five Star
had not entered into new geographic sales territories as described below. In
spite of this, the independent retailers that are Five Star's customers remain a
viable alternative to Home Depot and Lowe's, due to the shopping preferences of
and the retailer's geographic convenience for some consumers.

Five Star has continued to expand its sales territory with an addition, since
2000, of a sales force servicing the Mid-Atlantic States and as far south as
North Carolina, which has generated additional annual revenues of approximately
$10 million. Five Star services this territory from its existing New Jersey
warehouse, enabling Five Star to leverage its fixed costs over a broader revenue
base. To further expand, Five Star will attempt to grow its revenue base in the
Mid-Atlantic States, to acquire complementary distributors and to expand the
distribution of its use of private-label products sold under the "Five Star"
name. However, due to the spin-off, Five Star may have less financial resources
at its disposal with which to support and grow the business, as National Patent
Development will have a smaller market capitalization and less access to capital
markets than GP Strategies.

Operating Highlights

Three months ended March 31, 2005 compared to the three months ended March 31,
2004

For the three months ended March 31, 2005, the Company had a loss before income
tax expense and minority interests of $770,000 compared to a loss before income
tax expense and minority interests of $204,000 for the three months ended March
31, 2004. The decrease in pre-tax income is primarily a result of weaker segment
operating income, which declined by $422,000, increased corporate and other
general and administrative expenses of $235,000, increased interest expense of
$167,000; partially offset by increased investment and other income of $258,000.

Sales

                                                 Three months
                                               ended March 31,
                                           2005                 2004
                                           ----                 ----
    Five Star                             $28,239,000          $26,991,000
    MXL                                     1,838,000            2,130,000
                                        -------------       --------------
                                          $30,077,000          $29,121,000



                                       15
<PAGE>

The increase in Five Star sales of $1,248,000 was a result of increased sales
volume generated from the Company's annual trade shows; as well as rising prices
due to increased raw material costs for certain of the Company's vendors.

The decrease in MXL sales of $292,000 was a result of decreased revenues from
several customers at the Illinois facility and decreased revenues from MXL's
Massachusetts facility. In 2004, MXL exercised an option for an earlier
termination without penalty of the Massachusetts facility lease and exited the
facility in the first quarter of 2005, causing a disruption in production. MXL
relocated the inventory, machinery and equipment purchased from AOtec and is
consolidating its injection molding and precision coating operations at its
Lancaster, PA facility.

Gross margin

                                   Three months ended
                                       March 31,
                  -------------------------------------------------------
                  ---------------- --------- ----------------- ----------
                       2005             %            2004            %
                     --------            -         -------            -
   Five Star         $4,404,000        15.6       $4,469,000      16.6
   MXL                  145,000         7.9          296,000      13.9
                   ------------       -----     ------------      ----
                     $4,549,000        15.1       $4,765,000      16.4
                     ----------        ----       ----------      ----

Five Star gross margin decreased to $4,404,000, or 15.6% of net sales, for the
quarter ended March 31, 2005, as compared to $4,469,000, or 16.6% of net sales,
for the quarter ended March 31, 2004. The decrease in gross margin and gross
margin percentage for the quarter ended March 31, 2005 is primarily a result of
an unfavorable shift in the product mix sold and increased warehouse expenses.

MXL gross profit of $145,000, or 7.9% of sales, for the quarter ended March 31,
2005 decreased by $151,000 or 51% when compared to gross profit of $296,000, or
13.9% of sales, for the quarter ended March 31, 2004, mainly due to increases in
labor costs and raw material resin costs, as well as a less favorable product
mix.

Selling, general, and administrative expenses

For the three months ended March 31, 2005, selling, general and administrative
expenses increased by $441,000 from $4,669,000 for the three months ended March
31, 2004 to $5,110,000 partially due to increased general and administrative
expenses of $235,000 at the National Patent Development corporate level. Five
Star's selling, general and administrative expenses increased by $157,000
primarily attributable to increases in salesmen commissions, in delivery
expenses and in medical expenses; offset by a decrease in legal and professional
fees. MXL segment's selling, general and administrative expenses increased by
$49,000 primarily due to increased travel, research and development, and a loss
on sale of fixed assets.


                                       16
<PAGE>

Investment and other income (loss), net.

National Patent Development recognized investment and other income of $163,000
the three months ended March 31, 2005 mainly due a gain on sale of Millennium
Cell, Inc. common stock of $152,000; as compared to other losses of $95,000 for
the three months ended March 31, 2004, mainly due to a loss on sale of
Millennium Cell, Inc. common stock, offset by a gain on sale of Hemispherx
Biopharma, Inc. common stock

Income taxes

For the three months ended March 31, 2005 and 2004, the Company recorded an
income tax expense of $43,000, or an effective tax rate of 5.6%, and an income
tax benefit of $26,000, or an effective tax rate of 12.7%, respectively, which
represents the Company's applicable federal, state and local tax expense for the
periods.

Liquidity and capital resources

At March 31, 2005, the Company had cash and cash equivalents totaling of
$6,278,000. The Company believes that cash generated from operations and
borrowing availability under existing credit agreements will be sufficient to
fund the Company's working capital requirements for at least the next twelve
months.

For the three months ended March 31, 2005, National Patent Development's working
capital decreased by $419,000 to $13,609,000 from $14,028,000 as of December 31,
2004. The working capital decrease was primarily a result of a net loss for the
period.

The increase in cash and cash equivalents of $4,191,000 for the three months
ended March 31, 2005 resulted from net cash used in operations of $9,825,000,
due primarily to a net loss of $820,000, an increase in accounts receivable of
$8,135,000 and a decrease in accounts payable and accrued expenses of $748,000;
net cash provided by investing activities of $485,000, consisting of additions
to property, plant and equipment of $550,000, offset by proceeds on sale of
investments of $1,002,000 and proceeds on sales of property, plant and equipment
of $33,000; and net cash provided by financing activities of $13,531,000,
consisting of repayment of a receivable from GP Strategies of $5,000,000 and
proceeds of short term borrowings of $10,221,000, offset by repayments of
long-term debt of $1,690,000.

On July 3, 2001, MXL entered into a loan in the amount of $1,250,000, secured by
a mortgage covering the real estate and fixtures on its property in Illinois. At
December 31, 2004, $1,155,000 of such loan was outstanding. The loan requires
monthly payments of principal and interest in the amount of $11,046 with
interest at a fixed rate of 8.75% per annum, and matures on June 26, 2006, when
the remaining amount outstanding of approximately $1,100,000 is due in full. The
loan is guaranteed by GP Strategies. The proceeds of the loan were used to repay
a portion of the GP Strategies' short-term borrowings under its prior credit
agreement. As of March 31, 2005 and December 31, 2004, the mortgage has been
classified separately in the balance sheet as a current liability, as a result
of the classification of the Illinois property as held for sale.



                                       17
<PAGE>

On September 15, 2003, MXL purchased machinery, equipment and inventory from
AOtec, located in the Massachusetts area, for a purchase price of $1,100,000,
subject to adjustment. On August 1, 2003, MXL paid $100,000 of the purchase
price and issued three notes, in the amounts of $450,000, $275,000 and $275,000,
due October 1, 2003, August 5, 2004 and August 5, 2005, respectively
(collectively, the "AOtec Notes"). The AOtec Notes bear interest on the unpaid
principal amount at the rate of 4% per annum. On October 1, 2003, MXL borrowed
$700,000, or the AOtec Debt, from a bank to finance the purchase price and used
the proceeds to pay the $450,000 Note. The AOtec Debt is payable monthly for
three-years and is secured by the machinery and equipment purchased from AOtec.
GP Strategies guaranteed the AOtec Debt. MXL is currently negotiating a
reduction in the amounts due under the AOtec Notes with maturity dates of August
5, 2004 and 2005, resulting from a dispute over the purchase price. According to
the contract of sale, the payments due pursuant to the AOtec Notes were subject
to an offset and withholding by MXL. The parties are attempting to resolve this
matter; however there is no guarantee that MXL will successfully negotiate the
reduction of the AOtec notes. The AOtec Notes, which amount to $550,000 in the
aggregate following a repayment of $450,000 of the AOtec Notes in October 2003,
are included in short-term borrowings in the consolidated balance sheets.

In 2003, Five Star obtained a Loan and Security Agreement (the "Loan Agreement")
with Bank of America Business Capital (formerly Fleet Capital Corporation) (the
"Lender"). The Loan Agreement has a five-year term, with a maturity date of June
30, 2008. The Loan Agreement, as amended in March 2005, provides for a
$30,000,000 revolving credit facility, which allows Five Star to borrow based
upon a formula of up to 55% of eligible inventory and 80% of eligible accounts
receivable, as defined therein. The interest rates under the Loan Agreement
consist of LIBOR plus a credit spread of 2% (4.69% at March 31, 2005) for
borrowings not to exceed $15,000,000 and the prime rate (5.75% at March 31,
2005) for borrowings in excess of the above-mentioned LIBOR-based borrowings.
The credit spreads can be reduced in the event that Five Star achieves and
maintains certain performance benchmarks. At March 31, 2005 and December 31,
2004, approximately $27,955,000 and $18,234,000 was outstanding under the Loan
Agreement and approximately $521,000 and $434,000 was available to be borrowed,
respectively. Substantially all of Five Star's assets are pledged as collateral
for these borrowings. Under the Loan Agreement Five Star is subject to covenants
requiring minimum net worth, limitations on losses, if any, and minimum or
maximum values for certain financial ratios. As of March 31, 2005 Five Star was
in compliance with all required covenants.

In April 2005, Five Star amended the Loan Agreement to allow it to increase the
maximum amount that can be borrowed under the revolving credit facility to
$30,800,000 through June 30, 2005; reverting back to a maximum of $28,000,000 on
July 1, 2005.

On March 1, 2005, MXL obtained a Line of Credit Loan (the "MXL Line") from M&T
Bank with a one year term, maturing on March 1, 2006. The MXL Line provides for
a $1,000,000 revolving credit facility, which is secured by MXL's eligible


                                       18
<PAGE>

accounts receivable, inventory and a secondary claim on the Lancaster, PA
property. The interest rates under the MXL Line consist of LIBOR plus a credit
spread of 3% or the prime rate plus a credit spread of 0.25%. The MXL Line is
subject to an unused commitment fee of 0.25% of the average daily unused balance
of the line payable quarterly. National Patent Development has guaranteed the
MXL Line. At March 31, 2005, $500,000 was outstanding under the MXL Line and $0
was available to be borrowed.

Forward-looking statements

The forward-looking statements contained herein reflect National Patent
Development's management's current views with respect to future events and
financial performance. These forward-looking statements are subject to certain
risks and uncertainties that could cause actual results to differ materially
from those in the forward-looking statements, all of which are difficult to
predict and many of which are beyond the control of National Patent Development,
including, but not limited to the risks and uncertainties detailed in National
Patent Development's periodic reports and registration statements filed with the
Securities and Exchange Commission.




                                       19
<PAGE>



Item 3.    Quantitative and Qualitative Disclosure About Market Risk

  We have no material changes to the disclosure on this matter made in our
  report on Form 10-K for the fiscal year ended December 31, 2004.

Item 4.    Controls and Procedures

a.   Evaluation of disclosure controls and procedures. The Company's Chief
     Executive Officer and Chief Financial Officer have reviewed and evaluated
     the effectiveness of the Company's disclosure controls and procedures (as
     defined in Exchange Act Rules 240.13a-14(c) and 15d-14(c)) as of a date
     within ninety days before the filing date of this quarterly report. Based
     on that evaluation, the Chief Executive Officer and Chief Financial Officer
     have concluded that the Company's current disclosure controls and
     procedures are effective as of the evaluation date, providing them with
     material timely information relating to the Company required to be
     disclosed in the reports the Company files or submits under the Exchange
     Act.

b.   Changes in internal controls. There have been no significant changes in the
     Company's internal controls or in other factors that could significantly
     affect these controls subsequent to the date of their evaluation.





                                       20
<PAGE>



                           PART II. OTHER INFORMATION



Item 6.           Exhibits

                  a.       Exhibits


                           10.1 Second Modification Agreement dated as of March
                           22, 2005 by and between Five Star Group, Inc. as
                           borrower and Fleet Capital Corporation, as Lender.
                           Incorporated herein by reference to Exhibit 10.1 of
                           Five Star Products, Inc. Form 10-Q for the quarter
                           ended March 31, 2005.

                           31.1 Certification of Chief Executive Officer of the
                           Company dated May 16, 2005 pursuant to Securities and
                           Exchange Act Rule 13d-14(a)/15(d-14(a), as adopted
                           pursuant to Section 302 and 404 of the Sarbanes-Oxley
                           Act of 2002.*

                           31.2 Certification of Chief Financial Officer of the
                           Company dated May 16, 2005 pursuant to Securities and
                           Exchange Act Rule 13d-14(a)/15(d-14(a), as adopted
                           pursuant to Section 302 and 404 of the Sarbanes-Oxley
                           Act of 2002.*

                           32.2 Certification of Chief Executive Officer and
                           Chief Financial Officer of the Company dated May 16,
                           2005 pursuant to 18 U.S.C. Section 1350 as adopted
                           pursuant to Section 906 of the Sarbanes-Oxley Act of
                           2002.*

________

*Filed herewith


                                       21
<PAGE>





                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed in its behalf by the
undersigned thereunto duly authorized.


                               NATIONAL PATENT DEVELOPMENT CORPORATION


DATE: May 16, 2005             Jerome I. Feldman
                               Chairman of the Board and
                               Chief Executive Officer


DATE: May 16, 2005             Scott N. Greenberg
                               Chief Financial Officer


                                       22
<PAGE>